INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845P108 Class: Common Stock

BALYASNY ASSET MANAGEMENT L.P.'s Holding History (CIK: 0001218710)

Note: Option positions (PUT/CALL) are excluded.

Q4 2022
Shares 364,068 Value ($000) $4,504 Avg Close — Range —
Q3 2022
Shares 27,736 Value ($000) $387 Avg Close — Range —
Q2 2022
Shares 10,380 Value ($000) $143 Avg Close — Range —
Q4 2021
Shares 19,333 Value ($000) $315 Avg Close — Range —
Q3 2021
Shares 240,731 Value ($000) $3,575 Avg Close — Range —
Q1 2020
Shares 5,439 Value ($000) $342 Avg Close — Range —
Q4 2019
Shares 60,595 Value ($000) $7,509 Avg Close — Range —
Q3 2018
Shares 22,000 Value ($000) $2,780 Avg Close — Range —
Q2 2018
Shares 45,534 Value ($000) $3,821 Avg Close — Range —
Q4 2017
Shares 50,716 Value ($000) $2,963 Avg Close — Range —
Q3 2017
Shares 141,400 Value ($000) $8,207 Avg Close — Range —
Q2 2017
Shares 113,704 Value ($000) $13,766 Avg Close — Range —
Q4 2016
Shares 21,227 Value ($000) $2,306 Avg Close — Range —
Q3 2016
Shares 14,202 Value ($000) $2,338 Avg Close — Range —